239 related articles for article (PubMed ID: 23122042)
1. Diffusion-weighted imaging of the male pelvis.
Koh DM; Sohaib A
Radiol Clin North Am; 2012 Nov; 50(6):1127-44. PubMed ID: 23122042
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted MRI of adult male pelvic cancers.
Lim KS; Tan CH
Clin Radiol; 2012 Sep; 67(9):899-908. PubMed ID: 22498730
[TBL] [Abstract][Full Text] [Related]
3. Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications.
Punwani S
Eur J Radiol; 2011 Apr; 78(1):21-9. PubMed ID: 20801592
[TBL] [Abstract][Full Text] [Related]
4. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
Giannarini G; Petralia G; Thoeny HC
Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
[TBL] [Abstract][Full Text] [Related]
5. Pelvic applications of diffusion magnetic resonance images.
Coutinho AC; Krishnaraj A; Pires CE; Bittencourt LK; Guimarães AR
Magn Reson Imaging Clin N Am; 2011 Feb; 19(1):133-57. PubMed ID: 21129639
[TBL] [Abstract][Full Text] [Related]
6. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.
Jager GJ; Barentsz JO; Oosterhof GO; Witjes JA; Ruijs SJ
AJR Am J Roentgenol; 1996 Dec; 167(6):1503-7. PubMed ID: 8956585
[TBL] [Abstract][Full Text] [Related]
7. MR imaging of the pelvis.
Heiken JP; Lee JK
Radiology; 1988 Jan; 166(1 Pt 1):11-6. PubMed ID: 3336668
[No Abstract] [Full Text] [Related]
8. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis.
Mir N; Sohaib SA; Collins D; Koh DM
J Med Imaging Radiat Oncol; 2010 Aug; 54(4):358-64. PubMed ID: 20718916
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer.
Takeuchi M; Suzuki T; Sasaki S; Ito M; Hamamoto S; Kawai N; Kohri K; Hara M; Shibamoto Y
Acad Radiol; 2012 Jul; 19(7):827-33. PubMed ID: 22341371
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of the male pelvis.
Barentsz JO; Engelbrecht MR; Witjes JA; de la Rosette JJ; van der Graaf M
Eur Radiol; 1999; 9(9):1722-36. PubMed ID: 10602944
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis value of 3.0 T diffusion-weighted imaging with background suppression magnetic resonance for metastatic lymph nodes in rectal cancer].
Zhuang XZ; Yu SP; Cui J; Chen CQ; Zhao XJ; Pan BT; Li ZP
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):842-5. PubMed ID: 22116716
[TBL] [Abstract][Full Text] [Related]
12. [Visualization of prostatic, bladder and rectal cancer in nuclear magnetic resonance tomography].
Griebel J; Hess CF; Koelbel G; Kueper K
Rontgenpraxis; 1986 Jun; 39(6):196-205. PubMed ID: 3738623
[No Abstract] [Full Text] [Related]
13. Contrast-enhanced MR imaging of the bladder and prostate.
Siegelman ES; Schnall MD
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):153-69. PubMed ID: 8673712
[TBL] [Abstract][Full Text] [Related]
14. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases.
Papalia R; Simone G; Grasso R; Augelli R; Faiella E; Guaglianone S; Cazzato R; Del Vescovo R; Ferriero M; Zobel B; Gallucci M
BJU Int; 2012 Apr; 109(7):1031-6. PubMed ID: 21883835
[TBL] [Abstract][Full Text] [Related]
16. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of the prostate.
Iversen P; Kjaer L; Thomsen C; Henriksen O
Scand J Urol Nephrol Suppl; 1987; 104():41-5. PubMed ID: 3481468
[TBL] [Abstract][Full Text] [Related]
18. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
[TBL] [Abstract][Full Text] [Related]
19. Pelvic nodal imaging.
Hedgire SS; Pargaonkar VK; Elmi A; Harisinghani AM; Harisinghani MG
Radiol Clin North Am; 2012 Nov; 50(6):1111-25. PubMed ID: 23122041
[TBL] [Abstract][Full Text] [Related]
20. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
